Check API and finished-dose makers against cited filings and inspection history.
Sign up free with your work email and an emailed code. No password.
Search by molecule or open a supplier's profile to review its records.
See which API and finished-dose makers have filings for your molecule.
Review its plants and GMP certificates. Check the inspection history.
See who is approved to sell what in the market you're checking.
Save companies to your Watches. Each profile shows its latest approvals and inspections.
Rounded figures from the September 2026 data build.
Follow each answer back to its source.
Check DMF and CEP holders.
Check market registrations.
Review inspection history.
Find companies with registered products.
Check molecule patents.
PharmaDB's AI analyst answers from the same graph, with source links you can check.
Message Fred at +1 415 429 1791.
Give your work email, then enter the six-digit code sent to your inbox.
Send a text question. Fred can put longer answers on a page you can share.
Requires a PharmaDB account with a work email. Fred only replies; he never messages first.
Which Indian metformin API makers hold a CEP?
Three that hold valid metformin CEPs:
38 metformin API manufacturers are on record in total.
Want the source records?
PharmaDB is a web app for finding and vetting generic-drug suppliers. Its graph connects companies and molecules to manufacturing plants and regulatory records. Browse profiles and save suppliers to your Shortlist. The in-app assistant reads the page you're on.
PharmaDB is for API and finished-dose procurement and sourcing teams. Regulatory and quality teams use it to check supplier records. It also supports business development and market access work.
Yes. Sign up with your work email. Browsing the graph and profiles is free, as are Shortlist and Watches. Email alerts for Watches are coming soon.
Your email domain connects you with teammates in one shared workspace. Personal email addresses, including Gmail, aren't accepted. We email you a six-digit sign-in code, so there's no password to set.
The graph draws on regulatory filings and public records, including FDA inspections and EDQM CEPs. Every fact links to its source. Coverage figures reflect the September 2026 build. Recent changes may not yet appear; check the source date.
Fred is PharmaDB's AI analyst on WhatsApp. He answers text questions using the graph and the web, with links to sources. Sign in with your PharmaDB work email and code. Your thread also appears in the app. Fred only replies.
Start with the molecule you're sourcing.
Sign up free